Exact Mass: 370.1537316
Exact Mass Matches: 370.1537316
Found 206 metabolites which its exact mass value is equals to given mass value 370.1537316,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
thioridazine
N - Nervous system > N05 - Psycholeptics > N05A - Antipsychotics > N05AC - Phenothiazines with piperidine structure D002492 - Central Nervous System Depressants > D014149 - Tranquilizing Agents > D014150 - Antipsychotic Agents D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D014149 - Tranquilizing Agents D018377 - Neurotransmitter Agents > D015259 - Dopamine Agents > D018492 - Dopamine Antagonists D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants C78272 - Agent Affecting Nervous System > C29710 - Antipsychotic Agent
Thioridazine
A phenothiazine antipsychotic used in the management of psychoses, including schizophrenia, and in the control of severely disturbed or agitated behavior. It has little antiemetic activity. Thioridazine has a higher incidence of antimuscarinic effects, but a lower incidence of extrapyramidal symptoms, than chlorpromazine. (From Martindale, The Extra Pharmacopoeia, 30th ed, p618) N - Nervous system > N05 - Psycholeptics > N05A - Antipsychotics > N05AC - Phenothiazines with piperidine structure D002492 - Central Nervous System Depressants > D014149 - Tranquilizing Agents > D014150 - Antipsychotic Agents D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D014149 - Tranquilizing Agents D018377 - Neurotransmitter Agents > D015259 - Dopamine Agents > D018492 - Dopamine Antagonists D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants C78272 - Agent Affecting Nervous System > C29710 - Antipsychotic Agent
Cellulose, microcrystalline
Cellulose, microcrystalline is used as a food additive [EAFUS] ("EAFUS: Everything Added to Food in the United States. [http://www.eafus.com/]") D010592 - Pharmaceutic Aids > D014677 - Pharmaceutical Vehicles > D005079 - Excipients D001697 - Biomedical and Dental Materials
Apabetalone
C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS
1-[4-(Cyclooctylamino)pyridin-3-yl]sulfonyl-3-ethylthiourea
Brivanib
Methyl (3R,3'S,8'S,10'R)-2-oxospiro[1H-indole-3,12'-5,11-dioxa-1-azatricyclo[8.4.0.03,8]tetradec-6-ene]-7'-carboxylate
Telenzepine
(S)-4-(4-Hydroxyphenyl)-2-butanol 2-O-(6-O-acetyl)-??-D-glucopyranoside
5,5,6-Trimethyl-6-(1,2,3-triacetoxy-butyl)-5,6-dihydro-pyran-2-on|5,5,6-trimethyl-6-(1,2,3-triacetoxy-butyl)-5,6-dihydro-pyran-2-one
Tri-Ac-5, 6-Dihydro-6-(2, 4, 6-trihydroxyheptyl)-2H-pyran-2-one
Benzoyl-(+)-3-Hydroxyestra-1,3,5,7,9-pentaen-17-one
3-O-acetyl-4,5-O(2-methylbutyryl)-and propionylshikimic acid methyl ester|3-O-acetyl-4,5-O<2-methylbutyryl>-and propionylshikimic acid methyl ester
(E)-4-(3,4-dimethoxyphenyl)but-3-en-1-O-beta-D-glucopyranoside|(E)-4-(3,4-Dimethoxyphenyl)but-3-en-1-O-??-D-glucopyranoside
4-hydroxy-2-[(E)-4-hydroxy-3-methyl-2-butenyl]-5-methylphenyl beta-D-glucopyranoside|4-Hydroxy-2-[(E)-4-hydroxy-3-methyl-2-butenyl]-5-methylphenyl ??-D-glucopyranoside
2-O-Methyl-4-O-(6-methyl-beta-D-galaktopyranosyl)-D-galaktose
2-(1-propionylaminoethyl)thiazole-4-carboxylic acid [2-(1h-indol-3-yl)ethyl]amide
Ala Gly His Ser
Ala Gly Ser His
Ala His Gly Ser
Ala His Ser Gly
Ala Ser Gly His
Ala Ser His Gly
Gly Ala His Ser
Gly Ala Ser His
Gly Gly His Thr
Gly Gly Thr His
Gly His Ala Ser
Gly His Gly Thr
Gly His Ser Ala
Gly His Thr Gly
Gly Ser Ala His
Gly Ser His Ala
Gly Thr Gly His
Gly Thr His Gly
His Ala Gly Ser
His Ala Ser Gly
His Gly Ala Ser
His Gly Gly Thr
His Gly Ser Ala
His Gly Thr Gly
His Ser Ala Gly
His Ser Gly Ala
His Thr Gly Gly
4-hydroxy-3,5-bis(1-methylethyl)phenyl glucuronide
4-hydroxy-2,6-bis(1-methylethyl)phenyl glucuronide
Ser Ala Gly His
Ser Ala His Gly
Ser Gly Ala His
Ser Gly His Ala
Ser His Ala Gly
Ser His Gly Ala
Thr Gly Gly His
Thr Gly His Gly
Thr His Gly Gly
2,3-Dinor-6,15-diketo-13,14-dihydro-20-carboxyl-PGF1a
Cellulose gel
D010592 - Pharmaceutic Aids > D014677 - Pharmaceutical Vehicles > D005079 - Excipients D001697 - Biomedical and Dental Materials
Brivanib
A secondary alcohol resulting from the hydrolysis of the carboxylic ester group of brivanib alaninate. It is a dual VEGFR-2/FGFR-1 kinase inhibitor whose alanine prodrug, brivanib alaninate is currently under development as an oral agent for the treatment of cancer. C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C1967 - Tyrosine Kinase Inhibitor C274 - Antineoplastic Agent > C1742 - Angiogenesis Inhibitor
Thiourea, N-[2-(1H-benzimidazol-2-yl)ethyl]-N-[(4-fluorophenyl)methyl]-N-propyl- (9CI)
2,6-bis(4-azidobenzylidene)-4-methylcyclohexanone
C21H18N6O (370.15420179999995)
(S)-4-(anthracen-9-yl)-3-(tert-butyl)-2,3-dihydrobenzo[d][1,3]oxaphosphole
Telenzepine
C78272 - Agent Affecting Nervous System > C66880 - Anticholinergic Agent > C29704 - Antimuscarinic Agent D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents > D010276 - Parasympatholytics
1-[[4-[(4-fluoro-2-methyl-1H-indol-5-yl)oxy]-5-methyl-6-pyrrolo[2,1-f][1,2,4]triazinyl]oxy]-2-propanol
1-[4-(Cyclooctylamino)pyridin-3-yl]sulfonyl-3-ethylthiourea
3-methyl-N-[2-(4-morpholinyl)ethyl]-1-phenyl-5-thieno[2,3-c]pyrazolecarboxamide
7-[(E)-but-2-enyl]-3-methyl-8-(3-phenylpropylsulfanyl)purine-2,6-dione
ethyl 4-O-alpha-D-galactopyranosyl-beta-D-galactopyranoside
Disilane,1,1,2,2-tetramethyl-1,2-di-1-naphthalenyl-
Trimethylsilyl 2,6-bis[(trimethylsilyl)oxy]benzoate
C16H30O4Si3 (370.14518200000003)
Trimethylsilyl 3,4-bis(trimethylsilyloxy)benzoate
C16H30O4Si3 (370.14518200000003)
(2R)-N~4~-hydroxy-2-(3-hydroxybenzyl)-N~1~-[(1S,2R)-2-hydroxy-2,3-dihydro-1H-inden-1-yl]butanediamide
3-[(4-Hydroxybenzoyl)amino]azepan-4-YL 4-hydroxybenzoate
RVX-208
C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS
(2R,3R,4R,5R,6R)-5-{[(2S,3R,4R,5R,6R)-3,4-dihydroxy-6-(hydroxymethyl)-5-methoxyoxan-2-yl]oxy}-6-(hydroxymethyl)-2-methoxyoxane-3,4-diol
Methyl (3R,3S,8S,10R)-2-oxospiro[1H-indole-3,12-5,11-dioxa-1-azatricyclo[8.4.0.03,8]tetradec-6-ene]-7-carboxylate
5-[4-(2-Furylcarbonyl)piperazino]-5-oxo-3-phenylpentanoic acid
N-[2-(1-phenylethyl)-3,4-dihydro-1H-pyrazino[1,2-a]benzimidazol-8-yl]methanesulfonamide
5-(1,3-Benzodioxol-5-ylmethylamino)-2-(4-morpholinyl)benzoic acid methyl ester
4-methoxy-N-(3-methylbutyl)-3-(4-morpholinylsulfonyl)benzamide
C17H26N2O5S (370.15623460000006)
4-[[[[2-(3-Pyridinyl)-1-piperidinyl]amino]-sulfanylidenemethyl]amino]benzoic acid methyl ester
2-Amino-7-methyl-5-oxo-4-(2,4,5-trimethoxyphenyl)-4,6,7,8-tetrahydro-1-benzopyran-3-carbonitrile
[(2R)-3-[oxidanyl-[2-(trimethyl-$l^{4}-azanyl)ethoxy]phosphoryl]oxy-2-propanoyloxy-propyl] propanoate
C14H29NO8P+ (370.16307040000004)
2-Amino-7-methyl-5-oxo-4-(2,3,4-trimethoxyphenyl)-4,6,7,8-tetrahydro-1-benzopyran-3-carbonitrile
2-[[[2-[[(4-Methoxyphenyl)-oxomethyl]amino]phenyl]-oxomethyl]amino]-3-methylbutanoic acid
N-[(E)-[2-(1-methylpyridin-1-ium-2-yl)cyclohexylidene]amino]-2,4-dinitroaniline
C18H20N5O4+ (370.15152200000006)
[5-amino-1-(4-fluorophenyl)-1H-pyrazol-4-yl][3-(3-amino-2-hydroxypropoxy)phenyl]methanone
N-ethyl-N-[[(2S,3S,4R)-4-(hydroxymethyl)-1-(2-methoxy-1-oxoethyl)-3-phenyl-2-azetidinyl]methyl]methanesulfonamide
C17H26N2O5S (370.15623460000006)
N-ethyl-N-[[(2S,3R,4S)-4-(hydroxymethyl)-1-(2-methoxy-1-oxoethyl)-3-phenyl-2-azetidinyl]methyl]methanesulfonamide
C17H26N2O5S (370.15623460000006)
3,4,5-Trihydroxy-6-[1-(4-methoxyphenyl)pentan-3-yloxy]oxane-2-carboxylic acid
N-ethyl-N-[[(2S,3S,4S)-4-(hydroxymethyl)-1-(2-methoxy-1-oxoethyl)-3-phenyl-2-azetidinyl]methyl]methanesulfonamide
C17H26N2O5S (370.15623460000006)
N-ethyl-N-[[(2R,3S,4R)-4-(hydroxymethyl)-1-(2-methoxy-1-oxoethyl)-3-phenyl-2-azetidinyl]methyl]methanesulfonamide
C17H26N2O5S (370.15623460000006)
N-ethyl-N-[[(2R,3R,4R)-4-(hydroxymethyl)-1-(2-methoxy-1-oxoethyl)-3-phenyl-2-azetidinyl]methyl]methanesulfonamide
C17H26N2O5S (370.15623460000006)
N-ethyl-N-[[(2S,3R,4R)-4-(hydroxymethyl)-1-(2-methoxy-1-oxoethyl)-3-phenyl-2-azetidinyl]methyl]methanesulfonamide
C17H26N2O5S (370.15623460000006)
N-ethyl-N-[[(2R,3R,4S)-4-(hydroxymethyl)-1-(2-methoxy-1-oxoethyl)-3-phenyl-2-azetidinyl]methyl]methanesulfonamide
C17H26N2O5S (370.15623460000006)
N-ethyl-N-[[(2R,3S,4S)-4-(hydroxymethyl)-1-(2-methoxy-1-oxoethyl)-3-phenyl-2-azetidinyl]methyl]methanesulfonamide
C17H26N2O5S (370.15623460000006)
1-[(2S,3R)-6-[(4-chlorophenyl)methyl]-2-(hydroxymethyl)-3-phenyl-1,6-diazaspiro[3.3]heptan-1-yl]ethanone
2-[(6-amino-7H-purin-3-ium-8-yl)sulfanyl]-1-(4-phenylpiperazin-1-yl)ethanone
C17H20N7OS+ (370.14499700000005)
Trimethylsilyl 2,3-bis[(trimethylsilyl)oxy]benzoate
C16H30O4Si3 (370.14518200000003)
2-[2,3-Di(propanoyloxy)propoxy-hydroxyphosphoryl]oxyethyl-trimethylazanium
C14H29NO8P+ (370.16307040000004)
2,3-Dihydro-1,1,3,3-tetramethyl-1,3-disilaphenalene-2-spiro-1,2-dihydronaphthalene
2-[(3-Acetyloxy-2-butanoyloxypropoxy)-hydroxyphosphoryl]oxyethyl-trimethylazanium
C14H29NO8P+ (370.16307040000004)
alpha-D-Gal-(1->4)-beta-D-Gal-OEt
A glycoside that consists of ethyl beta-D-galactoside having an alpha-D-galactosyl residue at the 4-position.
(3,4,5-trihydroxy-6-{[4-(4-hydroxyphenyl)butan-2-yl]oxy}oxan-2-yl)methyl acetate
(1r,2r,3s)-1,2-bis(acetyloxy)-1-[(2s)-6-oxo-2,3-dihydropyran-2-yl]heptan-3-yl acetate
6'-acetyl-1,6-dimethoxy-10'-oxa-5'-azaspiro[indole-3,2'-tricyclo[5.3.1.0⁴,⁸]undecan]-5'-en-2-one
1-hydroxy-5,5,13-trimethyl-4-(3-oxobutanoyl)-4,13-diazatetracyclo[6.6.1.0²,⁶.0¹²,¹⁵]pentadeca-8,10,12(15)-triene-3,14-dione
4a,5,6,7,8-pentahydroxy-2,2-dimethyl-7-(3-methylbut-3-en-1-yn-1-yl)-hexahydro-1-benzopyran-3-yl acetate
4-hydroxy-2-[(e)-4-hydroxy-3-methyl-2-butenyl]-5-methylphenylβ-d-glucopyranoside
{"Ingredient_id": "HBIN010450","Ingredient_name": "4-hydroxy-2-[(e)-4-hydroxy-3-methyl-2-butenyl]-5-methylphenyl\u03b2-d-glucopyranoside","Alias": "NA","Ingredient_formula": "C18H26O8","Ingredient_Smile": "Not Available","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "10197","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
agarobiose dimethylacetal
{"Ingredient_id": "HBIN014820","Ingredient_name": "agarobiose dimethylacetal","Alias": "NA","Ingredient_formula": "C14H26O11","Ingredient_Smile": "COC(C(C1C(C(CO1)O)OC2C(C(C(C(O2)CO)O)O)O)O)OC","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "702","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}